Pfizer, Gilead and Incoming Eli Lilly CEO Discuss Why People Don't Like or Trust Pharma Companies
From EpiPens to insulin in the spotlight, the US public doesn't particularly love pharmaceutical companies at the moment.
At the Forbes Healthcare Summit on Thursday, a group of big pharma and biotech CEOs were asked to contemplate why the industry isn't liked — and things got tense.
The panel featured Gilead CEO John Milligan, Pfizer CEO Ian Read, incoming Eli Lilly CEO David Ricks, Astellas Americas President Jim Robinson, and Regeneron CEO Leonard Schleifer.
At the Forbes Healthcare Summit on Thursday, a group of big pharma and biotech CEOs were asked to contemplate why the industry isn't liked — and things got tense.
The panel featured Gilead CEO John Milligan, Pfizer CEO Ian Read, incoming Eli Lilly CEO David Ricks, Astellas Americas President Jim Robinson, and Regeneron CEO Leonard Schleifer.